Turki Y. Alhazzazi, Ph.D.
Affiliations: | 2012 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Cell Biology, OncologyGoogle:
"Turki Alhazzazi"Parents
Sign in to add mentor| Yvonne L. Kapila | grad student | 2012 | University of Michigan | |
| (Sirtuin-3 (SIRT3), a novel potential therapeutic target for head and neck cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Alhazzazi TY, Alghamdi FT. (2016) Head and Neck Cancer in Saudi Arabia: a Systematic Review. Asian Pacific Journal of Cancer Prevention : Apjcp. 17: 4043-8 |
| Alhazzazi TY. (2016) Evaluation of Head and Neck Cancer Awareness and Screening Status in Jeddah, Saudi Arabia. Asian Pacific Journal of Cancer Prevention : Apjcp. 17: 1135-9 |
| Alhazzazi TY, Kamarajan P, Xu Y, et al. (2016) A Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer Cells. Anticancer Research. 36: 49-60 |
| Alhazzazi TY, Kamarajan P, Verdin E, et al. (2013) Sirtuin-3 (SIRT3) and the Hallmarks of Cancer. Genes & Cancer. 4: 164-71 |
| Kamarajan P, Alhazzazi TY, Danciu T, et al. (2012) Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis. Cancer. 118: 5800-10 |
| Alhazzazi TY, Kamarajan P, Verdin E, et al. (2011) SIRT3 and cancer: tumor promoter or suppressor? Biochimica Et Biophysica Acta. 1816: 80-8 |
| Alhazzazi TY, Kamarajan P, Joo N, et al. (2011) Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer. Cancer. 117: 1670-8 |
| Kamarajan P, Alhazzazi T, D'Silva N, et al. (2011) Abstract 4768: Receptor interacting protein (RIP) and Sirtuin-3 (SIRT3) on opposite sides of anoikis resistance and promotes tumorigenesis Cancer Research. 71: 4768-4768 |